Physician

Paul A Bannen, MD

According to 2025 Medicare claims, Paul Bannen, MD (NPI: 1942392899) practices medical oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is RCCA MD LLC (NPI: 1467800367; TIN: 812588874) and primary practice location at 20832-1507.

Bannen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 843 traditional Medicare patients, billed 268,522 HCPCS/CPT codes, and received $3,737,728 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,037 prescription claims across 212 beneficiaries totaling $3,325,142 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 28 claims. Open Payments data shows 4 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,479,923 to $3,737,728. Similarly, Part D prescription costs have moved sharply higher in recent years, from $770,974 to $3,325,142. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.5M2015 Medicare payment: $1,479,923 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,641,884 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,077,427 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,720,393 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,979,428 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,606,650 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,294,780 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,470,917 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,717,927 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,737,728 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015875229,070$1,479,923
2016840208,665$1,641,884
2017898180,546$2,077,427
2018920222,585$2,720,393
2019998245,865$2,979,428
2020858239,760$3,606,650
2021883300,151$4,294,780
2022905263,041$4,470,917
2023897231,978$3,717,927
2024843268,522$3,737,728

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2015 Drug cost: $770,974 (USD; Tot_Drug_Cst)2016 Drug cost: $786,850 (USD; Tot_Drug_Cst)2017 Drug cost: $1,059,205 (USD; Tot_Drug_Cst)2018 Drug cost: $1,241,063 (USD; Tot_Drug_Cst)2019 Drug cost: $1,431,008 (USD; Tot_Drug_Cst)2020 Drug cost: $1,497,829 (USD; Tot_Drug_Cst)2021 Drug cost: $1,670,711 (USD; Tot_Drug_Cst)2022 Drug cost: $2,406,546 (USD; Tot_Drug_Cst)2023 Drug cost: $2,897,218 (USD; Tot_Drug_Cst)2024 Drug cost: $3,325,142 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015138756$770,974
2016124702$786,850
2017130765$1,059,205
2018141703$1,241,063
2019159683$1,431,008
2020153734$1,497,829
2021137570$1,670,711
2022148649$2,406,546
2023155693$2,897,218
20242121,037$3,325,142

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$19K$39K2015 Medicare payment: $38,943 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $10,831 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $17,757 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,964 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $6,328 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,494 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,371 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,833 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $952 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R87$38,943
2016N/R22$10,831
2017N/R51$17,757
2018N/R22$2,964
2019N/R47$6,328
2020N/R32$2,494
2021N/R12$1,371
2022N/RN/RN/R
2023N/R68$8,833
2024N/R28$952

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7341,877$115
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more282392$73
80053Blood test, comprehensive group of blood chemicals5992,268$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count8144,054$8
96160Administration and interpretation of patient-focused health risk assessment274311$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide27756$613,677
PromactaEltrombopag Olamine23690$322,744
RevlimidLenalidomide17469$304,044
BrukinsaZanubrutinib22654$302,273
CalquenceAcalabrutinib Maleate13390$199,905

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R15$707
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$245

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$32Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.2$9,000Cornerstone Specialty Network LLC

FAQ

What Medicare data is available for Paul A. Bannen, MD?

Tedicare shows public-source Medicare data for Paul A. Bannen, MD (NPI 1942392899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul A. Bannen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul A. Bannen, MD?

Paul A. Bannen, MD is linked to RCCA MD LLC (billing NPI 1467800367) in the available physician profile data.

Does Paul A. Bannen, MD have Open Payments data?

Paul A. Bannen, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.